Flavoxate hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for flavoxate hydrochloride and what is the scope of freedom to operate?
Flavoxate hydrochloride
is the generic ingredient in two branded drugs marketed by Epic Pharma, Impax Pharms, Padagis Us, and Ortho Mcneil Janssen, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for flavoxate hydrochloride. Three suppliers are listed for this compound.
Summary for flavoxate hydrochloride
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 4 |
Drug Master File Entries: | 8 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Clinical Trials: | 3 |
Patent Applications: | 1,622 |
What excipients (inactive ingredients) are in flavoxate hydrochloride? | flavoxate hydrochloride excipients list |
DailyMed Link: | flavoxate hydrochloride at DailyMed |
Recent Clinical Trials for flavoxate hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Calgary | Phase 4 |
Mahidol University | Phase 4 |
Paddock Laboratories, Inc. | Phase 1 |
Pharmacology for flavoxate hydrochloride
Drug Class | Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for flavoxate hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for flavoxate hydrochloride
US Patents and Regulatory Information for flavoxate hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax Pharms | FLAVOXATE HYDROCHLORIDE | flavoxate hydrochloride | TABLET;ORAL | 076234-001 | Aug 28, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Padagis Us | FLAVOXATE HYDROCHLORIDE | flavoxate hydrochloride | TABLET;ORAL | 076831-001 | Dec 16, 2004 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ortho Mcneil Janssen | URISPAS | flavoxate hydrochloride | TABLET;ORAL | 016769-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma | FLAVOXATE HYDROCHLORIDE | flavoxate hydrochloride | TABLET;ORAL | 076835-001 | Nov 30, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.